跳至主要内容
临床试验/NCT00309543
NCT00309543已完成3 期

A Prospectively Randomized Study on Adjuvant Chemotherapy in Patients With Operated Colon Carcinoma Dukes B (Stage II; T3-4, N0, M0).

Austrian Breast & Colorectal Cancer Study Group36 个研究点 分布在 1 个国家目标入组 636 人开始时间: 1993年11月1日最近更新:
适应症
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
636
试验地点
36
主要终点
Overall survival

研究概览

简要总结

This clinical investigation examined the influence of cytostatic chemotherapy with 5-fluorouracil, modulated by biologically active leucovorin, on patients' survival time following surgery for colon carcinoma Stage II.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with histologically verified, operable colon carcinoma Stage II (RO, T3-4, N0, M0)
  • Age: less than 80 years
  • WHO Performance > 2
  • Adequate bone marrow reserve, renal and hepatic functions
  • Informed consent

排除标准

  • Rectal cancer
  • R1or R2 resection; carcinosis peritonei
  • Start of treatment > 42 days postop; other adjuvant radiotherapy, chemotherapy or immunotherapy
  • Serious concomitant disease, in particular chronically inflammatory large intestine, cardiopathic or metabolic disease, malignant second carcinoma

结局指标

主要结局

Overall survival

次要结局

未报告次要终点

研究者

研究点 (36)

Loading locations...

相似试验